Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wherefore art thou Romeo?

Robin D G Cooper

    Current Opinion in Investigational Drugs (London, England : 2000)
    |December 18, 2004
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A class of small molecules that inhibit TNFalpha-induced survival and death pathways via prevention of interactions between TNFalphaRI, TRADD, and RIP1.

    Chemistry & biology·2007
    Same author

    Azetidinones as vasopressin V1a antagonists.

    Bioorganic & medicinal chemistry·2007
    Same author

    Glycopeptide carboxamides active against vancomycin-resistant enterococci.

    The Journal of antibiotics·2003
    Same journal

    Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?

    Current opinion in investigational drugs (London, England : 2000)·2011
    Same journal

    Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.

    Current opinion in investigational drugs (London, England : 2000)·2010
    Same journal

    Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.

    Current opinion in investigational drugs (London, England : 2000)·2010
    Same journal

    Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.

    Current opinion in investigational drugs (London, England : 2000)·2010
    Same journal

    Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.

    Current opinion in investigational drugs (London, England : 2000)·2010
    Same journal

    Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.

    Current opinion in investigational drugs (London, England : 2000)·2010
    See all related articles